Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota,Journal of Applied Microbiology

当前位置： X-MOL 学术 › J. Appl. Microbiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota
Journal of Applied Microbiology ( IF 3.2 ) Pub Date : 2020-12-01 , DOI: 10.1111/jam.14952
C L Bao ₁ , S Z Liu ₂ , Z D Shang ₂ , Y J Liu ₁ , J Wang ₁ , W X Zhang ₁ , B Dong ₁ , Y H Cao ₁

Affiliation

This study evaluated the effects of Bacillus amyloliquefaciens TL106, isolated from Tibetan pigs’ faeces, on the growth performance, immune response, intestinal barrier function, morphology of jejunum, caecum and colon, and gut microbiota in the mice with enterohaemorrhagic Escherichia coli (EHEC)-induced intestinal diseases.

中文翻译：

解淀粉芽孢杆菌 TL106 通过改善免疫反应、肠道屏障功能和肠道微生物群保护小鼠免受肠出血性大肠杆菌 O157:H7 诱导的肠道疾病

本研究评估了从藏猪粪便中分离的解淀粉芽孢杆菌TL106 对肠出血性大肠杆菌(EHEC)小鼠生长性能、免疫反应、肠道屏障功能、空肠、盲肠和结肠形态以及肠道微生物群的影响-诱发肠道疾病。

更新日期：2020-12-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11